Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous diazepam plus fentanyl versus midazolam plus fentanyl for shoulder dislocation reduction
IRCT20170313033051N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Glenohumeral dislocation (GHD) comparing Diazepam + fentanyl with Midazolam + fentanyl (2 arms). Primary endpoints: Pain assessment, Adverse drug reactions and 2 more. Started Feb 2019; status: completed.
02
Drugs
diazepammidazolamfentanyl
03
Conditions
Glenohumeral dislocation (GHD)
Beyond the preview
Go deeper on IRCT20170313033051N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170313033051N1.